{
  "main_header": {
    "sid": 10039308,
    "name": "Emcure Pharma",
    "stock_name": "Emcure Pharma",
    "full_name": "Emcure Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/emcure-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,998.85",
    "chg": 1.85,
    "chgp": "0.09%",
    "dir": 1,
    "prev_price": "1,997.00",
    "mcapval": "37,936.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544210,
    "symbol": "EMCURE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE168P01015",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "2.06 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4000693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_mojoScore_4000693.png",
        "date": "2026-05-20 10:10:56",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-valuation-shifts-signal-caution-amid-strong-returns-3997949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_valuationdot_3997949.png",
        "date": "2026-05-19 08:03:05",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable change in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, prompting a reassessment of its price attractiveness amid sector peers and historical benchmarks. Despite strong operational metrics, the stock’s elevated price-to-earnings and price-to-book ratios suggest a cautious stance for investors evaluating entry or exit points."
      }
    ],
    "total": 15,
    "sid": "10039308",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/emcure-pharmaceuticals-10039308"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "08-Aug-2026",
      "details": "Update on USFDA inspection at our formulations facility located at Sanand Ahmedabad Gujarat India",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "07-Aug-2026",
      "details": "Analyst/Investor Meet on Wednesday August 12 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Emcure Pharmaceuticals Ltd is Rated Hold

2026-05-20 10:10:56

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read More

Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns

2026-05-19 08:03:05

Emcure Pharmaceuticals Ltd has experienced a notable change in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, prompting a reassessment of its price attractiveness amid sector peers and historical benchmarks. Despite strong operational metrics, the stock’s elevated price-to-earnings and price-to-book ratios suggest a cautious stance for investors evaluating entry or exit points.

Read More

View All News